col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer Science and Business Media LLC: Nature Medicine
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―22 Caution before fractionating COVID-19 vaccines Annelies Wilder-Smith, Shalini Desai, Alejandro Cravioto, Hanna Nohynek, Joachim Hombach
2 [GO] 2021―Sep―15 Federated learning for predicting clinical outcomes in patients with COVID-19 Ittai Dayan, Holger R. Roth, Aoxiao Zhong, Ahmed Harouni, Amilcare Gentili, Anas Z. Abidin, et al. (+93)
3 [GO] 2021―Sep―15 Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis Angela Choi, Matthew Koch, Kai Wu, Laurence Chu, LingZhi Ma, Anna Hill, et al. (+16)
4 [GO] 2021―Sep―14 How patient data underpin COVID-19 research Marion Renault
5 [GO] 2021―Sep―14 Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter, Rishi R. Goel, Divij Mathew, Kerry Lenzi, et al. (+22)
6 [GO] 2021―Sep―13 A government-led effort to identify correlates of protection for COVID-19 vaccines Richard A. Koup, Ruben O. Donis, Peter B. Gilbert, Andrew W. Li, Najaf A. Shah, Christopher R. Houchens
7 [GO] 2021―Sep―13 Can space-based technologies help manage and prevent pandemics? Farhan M. Asrar, David Saint-Jacques, Helena J. Chapman, Dave Williams, Shirish Ravan, Ross Upshur, Jonathan B. Clark
8 [GO] 2021―Sep―09 Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial Philippe Bégin, Jeannie Callum, Erin Jamula, Richard Cook, Nancy M. Heddle, Alan Tinmouth, et al. (+621)
9 [GO] 2021―Sep―09 The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology Bas B. Oude Munnink, Nathalie Worp, David F. Nieuwenhuijse, Reina S. Sikkema, Bart Haagmans, Ron A. M. Fouchier, Marion Koopmans
10 [GO] 2021―Sep―07 Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy Noa Dagan, Noam Barda, Tal Biron-Shental, Maya Makov-Assif, Calanit Key, Isaac S. Kohane, et al. (+5)
11 [GO] 2021―Sep―06 Balancing incentives and disincentives for vaccination in a pandemic Julian Savulescu, Jonathan Pugh, Dominic Wilkinson
12 [GO] 2021―Sep―03 Calming the cytokine storm in COVID-19 Randy Q. Cron, Roberto Caricchio, W. Winn Chatham
13 [GO] 2021―Sep―03 Predictors of COVID-19 epidemics in countries of the World Health Organization African Region Feifei Zhang, Humphrey Karamagi, Ngoy Nsenga, Miriam Nanyunja, Miriam Karinja, Seth Amanfo, et al. (+15)
14 [GO] 2021―Sep―03 Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial Evdoxia Kyriazopoulou, Garyfallia Poulakou, Haralampos Milionis, Simeon Metallidis, Georgios Adamis, Konstantinos Tsiakos, et al. (+58)
15 [GO] 2021―Aug―31 COVID-19 boosters in rich nations will delay vaccines for all Zain Chagla, Madhukar Pai
16 [GO] 2021―Aug―23 Lessons on COVID-19 from Indigenous and remote communities of the Arctic Andrey N. Petrov, Mark Welford, Nikolay Golosov, John DeGroote, Michele Devlin, Tatiana Degai, Alexander Savelyev
17 [GO] 2021―Aug―19 Effects of a large-scale social media advertising campaign on holiday travel and COVID-19 infections: a cluster randomized controlled trial Emily Breza, Fatima Cody Stanford, Marcella Alsan, Burak Alsan, Abhijit Banerjee, Arun G. Chandrasekhar, et al. (+15)
18 [GO] 2021―Aug―16 Southeast Asia is an emerging hotspot for COVID-19 Thanat Chookajorn, Theerarat Kochakarn, Chaiwat Wilasang, Namfon Kotanan, Charin Modchang
19 [GO] 2021―Jul―26 A ‘mix and match’ approach to SARS-CoV-2 vaccination Meagan E. Deming, Kirsten E. Lyke
20 [GO] 2021―Jul―26 Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination Tina Schmidt, Verena Klemis, David Schub, Janine Mihm, Franziska Hielscher, Stefanie Marx, et al. (+9)
21 [GO] 2021―Jul―16 COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries Julio S. Solís Arce, Shana S. Warren, Niccolò F. Meriggi, Alexandra Scacco, Nina McMurry, Maarten Voors, et al. (+68)
22 [GO] 2021―Jul―16 Understanding COVID-19 vaccine hesitancy Shingai Machingaidze, Charles Shey Wiysonge
23 [GO] 2021―Jul―15 Another COVID-19 vaccine to boost rollout Karen O’Leary
24 [GO] 2021―Jul―14 Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination Joana Barros-Martins, Swantje I. Hammerschmidt, Anne Cossmann, Ivan Odak, Metodi V. Stankov, Gema Morillas Ramos, et al. (+19)
25 [GO] 2021―Jul―12 A French cohort for assessing COVID-19 vaccine responses in specific populations Paul Loubet, Linda Wittkop, Eric Tartour, Beatrice Parfait, Benoit Barrou, Jean-Yves Blay, et al. (+15)
26 [GO] 2021―Jul―09 mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar Hiam Chemaitelly, Hadi M. Yassine, Fatiha M. Benslimane, Hebah A. Al Khatib, Patrick Tang, Mohammad R. Hasan, et al. (+18)
27 [GO] 2021―Jul―09 A human three-dimensional neural-perivascular ‘assembloid’ promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology Lu Wang, David Sievert, Alex E. Clark, Sangmoon Lee, Hannah Federman, Benjamin D. Gastfriend, et al. (+4)
28 [GO] 2021―Jul―08 Engineered face masks detect COVID-19 Karen O’Leary
29 [GO] 2021―Jul―08 A correlate of protection for SARS-CoV-2 vaccines is urgently needed Florian Krammer
30 [GO] 2021―Jul―05 Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality Benjamin J. Cowling, Wey Wen Lim, Sarah Cobey
31 [GO] 2021―Jul―05 Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians C. S. Pramesh, Giridhara R. Babu, Joyeeta Basu, Indu Bhushan, Christopher M. Booth, Girish Chinnaswamy, et al. (+12)
32 [GO] 2021―Jun―29 Reduction in life expectancy in Brazil after COVID-19 Marcia C. Castro, Susie Gurzenda, Cassio M. Turra, Sun Kim, Theresa Andrasfay, Noreen Goldman
33 [GO] 2021―Jun―28 Emergence of measles during the COVID-19 pandemic threatens Pakistan’s children and the wider region Muhammad Suleman Rana, Muhammad Masroor Alam, Aamer Ikram, Muhammad Salman, Mohammad Osama Mere, Muhammad Usman, et al. (+3)
34 [GO] 2021―Jun―28 Asian healthcare workers in the COVID-19 pandemic: a long road to recovery Jo-Hsuan Wu
35 [GO] 2021―Jun―28 Building a pandemic-proof vaccine Karen O’Leary
36 [GO] 2021―Jun―21 Brazil needs a coordinated and cooperative approach to tackle COVID-19 Lorena G. Barberia, Silvia Figueiredo Costa, Ester C. Sabino
37 [GO] 2021―Jun―21 Has SARS-CoV-2 reached peak fitness? Roberto Burioni, Eric J. Topol
38 [GO] 2021―Jun―18 Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19 Carolina Lucas, Jon Klein, Maria E. Sundaram, Feimei Liu, Patrick Wong, Julio Silva, et al. (+99)
39 [GO] 2021―Jun―14 Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals Talia Kustin, Noam Harel, Uriah Finkel, Shay Perchik, Sheri Harari, Maayan Tahor, et al. (+23)
40 [GO] 2021―Jun―10 Strengthened health systems are needed to tackle COVID-19 in Africa Moses Alobo
41 [GO] 2021―Jun―10 Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals Oren Milman, Idan Yelin, Noga Aharony, Rachel Katz, Esma Herzel, Amir Ben-Tov, et al. (+5)
42 [GO] 2021―Jun―09 First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland C. R. Simpson, T. Shi, E. Vasileiou, S. V. Katikireddi, S. Kerr, E. Moore, et al. (+24)
43 [GO] 2021―Jun―09 Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, David W. Eyre, Owen Gethings, Karina-Doris Vihta, et al. (+14)
44 [GO] 2021―Jun―09 COVID-19 vaccination and immune thrombocytopenia Allyson M. Pishko, James B. Bussel, Douglas B. Cines
45 [GO] 2021―Jun―03 High COVID-19 death toll in Africa Karen O’Leary
46 [GO] 2021―May―31 After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases Mike May
47 [GO] 2021―May―27 SARS-CoV-2 variants of concern are emerging in India Jasdeep Singh, Syed Asad Rahman, Nasreen Z. Ehtesham, Subhash Hira, Seyed E. Hasnain
48 [GO] 2021―May―25 COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence Felipe Gomes Naveca, Valdinete Nascimento, Victor Costa de Souza, André de Lima Corado, Fernanda Nascimento, George Silva, et al. (+23)
49 [GO] 2021―May―24 To curb COVID-19, global health must go local
50 [GO] 2021―May―24 The world needs an intergovernmental panel on pandemic risk Ben Oppenheim, Kaysie Brown, Ron Waldman
51 [GO] 2021―May―21 Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial Katie J. Ewer, Jordan R. Barrett, Sandra Belij-Rammerstorfer, Hannah Sharpe, Rebecca Makinson, Richard Morter, et al. (+40)
52 [GO] 2021―May―20 CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer Erin M. Bange, Nicholas A. Han, Paul Wileyto, Justin Y. Kim, Sigrid Gouma, James Robinson, et al. (+54)
53 [GO] 2021―May―18 Equitable allocation of COVID-19 vaccines in the United States Harald Schmidt, Rebecca Weintraub, Michelle A. Williams, Kate Miller, Alison Buttenheim, Emily Sadecki, et al. (+5)
54 [GO] 2021―May―18 Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19 Brian J. Ward, Philipe Gobeil, Annie Séguin, Judith Atkins, Iohann Boulay, Pierre-Yves Charbonneau, et al. (+13)
55 [GO] 2021―May―17 Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries Victoria Haldane, Chuan De Foo, Salma M. Abdalla, Anne-Sophie Jung, Melisa Tan, Shishi Wu, et al. (+14)
56 [GO] 2021―May―17 Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection David S. Khoury, Deborah Cromer, Arnold Reynaldi, Timothy E. Schlub, Adam K. Wheatley, Jennifer A. Juno, et al. (+4)
57 [GO] 2021―May―13 Tocilizumab for the treatment of severe COVID-19 Karen O’Leary
58 [GO] 2021―May―10 SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies Emanuele Andreano, Rino Rappuoli
59 [GO] 2021―May―10 Sustained behavior change is key to preventing and tackling future pandemics Susan Michie, Robert West
60 [GO] 2021―May―06 Overcoming Brazil’s monumental COVID-19 failure: an urgent call to action Pedro C. Hallal, Cesar G. Victora
61 [GO] 2021―May―06 Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses Jordan R. Barrett, Sandra Belij-Rammerstorfer, Christina Dold, Katie J. Ewer, Pedro M. Folegatti, Ciaran Gilbride, et al. (+48)
62 [GO] 2021―May―05 Delayed production of neutralizing antibodies correlates with fatal COVID-19 Carolina Lucas, Jon Klein, Maria E. Sundaram, Feimei Liu, Patrick Wong, Julio Silva, et al. (+31)
63 [GO] 2021―May―04 Author Correction: What do journalists say about covering science during the COVID-19 pandemic? Anita Makri
64 [GO] 2021―May―04 Author Correction: Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group Jerome Amir Singh, Sonali Kochhar, Jonathan Wolff
65 [GO] 2021―Apr―29 COVID-19 vaccine and blood clotting
66 [GO] 2021―Apr―26 Being fair to participants in placebo-controlled COVID-19 vaccine trials Rafael Dal-Ré, Walter Orenstein, Arthur L. Caplan
67 [GO] 2021―Apr―22 Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study Jingxin Li, Aimin Hui, Xiang Zhang, Yumei Yang, Rong Tang, Huayue Ye, et al. (+16)
68 [GO] 2021―Apr―20 Single-cell multi-omics analysis of the immune response in COVID-19 Emily Stephenson, Gary Reynolds, Rachel A. Botting, Fernando J. Calero-Nieto, Michael D. Morgan, Zewen Kelvin Tuong, et al. (+62)
69 [GO] 2021―Apr―19 Leave no one behind: ensuring access to COVID-19 vaccines for refugee and displaced populations Monette Zard, Ling San Lau, Diana M. Bowser, Fouad M. Fouad, Diego I. Lucumí, Goleen Samari, et al. (+7)
70 [GO] 2021―Apr―19 COVID-19 dynamics after a national immunization program in Israel Hagai Rossman, Smadar Shilo, Tomer Meir, Malka Gorfine, Uri Shalit, Eran Segal
71 [GO] 2021―Apr―16 Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy Giulia Giordano, Marta Colaneri, Alessandro Di Filippo, Franco Blanchini, Paolo Bolzern, Giuseppe De Nicolao, et al. (+3)
72 [GO] 2021―Apr―15 Comprehensive large-scale nucleic acid-testing strategies support China’s sustained containment of COVID-19 Zhongjie Li, Fengfeng Liu, Jinzhao Cui, Zhibin Peng, Zhaorui Chang, Shengjie Lai, et al. (+4)
73 [GO] 2021―Apr―15 “I had to be with bodyguards with guns”-attacks on scientists during the pandemic Anita Makri
74 [GO] 2021―Apr―09 Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 Liam Gaziano, Claudia Giambartolomei, Alexandre C. Pereira, Anna Gaulton, Daniel C. Posner, Sonja A. Swanson, et al. (+50)
75 [GO] 2021―Apr―07 Africa needs more genome sequencing to tackle new variants of SARS-CoV-2 Akaninyene Otu, Emmanuel Agogo, Bassey Ebenso
76 [GO] 2021―Apr―05 Changing climate and the COVID-19 pandemic: more than just heads or tails Xavier Rodó, Adrià San-José, Karin Kirchgatter, Leonardo López
77 [GO] 2021―Apr―01 Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 Joseph E. Ebinger, Justyna Fert-Bober, Ignat Printsev, Min Wu, Nancy Sun, John C. Prostko, et al. (+6)
78 [GO] 2021―Mar―30 Public opinion on global rollout of COVID-19 vaccines Philip M. Clarke, Laurence S. J. Roope, Peter John Loewen, Jean-Francois Bonnefon, Alessia Melegaro, Jorge Friedman, et al. (+3)
79 [GO] 2021―Mar―29 Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine Matan Levine-Tiefenbrun, Idan Yelin, Rachel Katz, Esma Herzel, Ziv Golan, Licita Schreiber, et al. (+8)
80 [GO] 2021―Mar―26 Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies Delphine Planas, Timothée Bruel, Ludivine Grzelak, Florence Guivel-Benhassine, Isabelle Staropoli, Françoise Porrot, et al. (+27)
81 [GO] 2021―Mar―25 SARS-CoV-2 infection of the oral cavity and saliva Ni Huang, Paola Pérez, Takafumi Kato, Yu Mikami, Kenichi Okuda, Rodney C. Gilmore, et al. (+46)
82 [GO] 2021―Mar―22 Post-acute COVID-19 syndrome Ani Nalbandian, Kartik Sehgal, Aakriti Gupta, Mahesh V. Madhavan, Claire McGroder, Jacob S. Stevens, et al. (+28)
83 [GO] 2021―Mar―16 Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group Jerome Amir Singh, Sonali Kochhar, Jonathan Wolff
84 [GO] 2021―Mar―15 Nowcasting epidemics of novel pathogens: lessons from COVID-19 Joseph T. Wu, Kathy Leung, Tommy T. Y. Lam, Michael Y. Ni, Carlos K. H. Wong, J. S. Malik Peiris, Gabriel M. Leung
85 [GO] 2021―Mar―15 COVID-19: unprecedented but expected John N. Nkengasong
86 [GO] 2021―Mar―15 Tracking the emergence of new SARS-CoV-2 variants in South Africa Anise N. Happi, Chinedu A. Ugwu, Christian T. Happi
87 [GO] 2021―Mar―15 Beyond recruitment: good participatory practice enhances the impact of research in a pandemic Barthalomew Wilson, Katharine Wright, Robert Taylor, Elizabeth Higgs
88 [GO] 2021―Mar―15 Hindsight is 2020? Lessons in global health governance one year into the pandemic Ines Hassan, Mitsuru Mukaigawara, Lois King, Genevie Fernandes, Devi Sridhar
89 [GO] 2021―Mar―15 Preparing for the next pandemic
90 [GO] 2021―Mar―15 Will this pandemic be the catalyst to finally reform humanitarian responses? Paul B. Spiegel
91 [GO] 2021―Mar―15 Art in a pandemic: a digital gallery Hannah Stower, Marianne Guennot
92 [GO] 2021―Mar―11 The battle for COVID-19 vaccines highlights the need for a new global governance mechanism Anna Mia Ekström, Camilla Berggren, Göran Tomson, Lawrence O. Gostin, Peter Friberg, Ole Petter Ottersen
93 [GO] 2021―Mar―04 Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies Rita E. Chen, Xianwen Zhang, James Brett Case, Emma S. Winkler, Yang Liu, Laura A. VanBlargan, et al. (+26)
94 [GO] 2021―Mar―02 SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, Mashudu Madzivhandila, Prudence Kgagudi, Brent Oosthuysen, et al. (+13)
95 [GO] 2021―Mar―02 Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics Christoph Muus, Malte D. Luecken, Gökcen Eraslan, Lisa Sikkema, Avinash Waghray, Graham Heimberg, et al. (+108)
96 [GO] 2021―Mar―01 Assessing the human immune response to SARS-CoV-2 variants Roberto Burioni, Eric J. Topol
97 [GO] 2021―Feb―25 A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity Sirui Zhou, Guillaume Butler-Laporte, Tomoko Nakanishi, David R. Morrison, Jonathan Afilalo, Marc Afilalo, et al. (+35)
98 [GO] 2021―Feb―17 Time to evaluate COVID-19 contact-tracing apps Vittoria Colizza, Eva Grill, Rafael Mikolajczyk, Ciro Cattuto, Adam Kucharski, Steven Riley, et al. (+7)
99 [GO] 2021―Feb―17 A dangerous measles future looms beyond the COVID-19 pandemic David N. Durrheim, Jon K. Andrus, Shahina Tabassum, Hyam Bashour, David Githanga, Günter Pfaff
100 [GO] 2021―Feb―17 COVID-19 vaccination: the VOICE for patients with cancer Astrid A. M. van der Veldt, Sjoukje F. Oosting, Anne-Marie C. Dingemans, Rudolf S. N. Fehrmann, Corine GeurtsvanKessel, Mathilde Jalving, et al. (+13)
101 [GO] 2021―Feb―17 Humoral signatures of protective and pathological SARS-CoV-2 infection in children Yannic C. Bartsch, Chuangqi Wang, Tomer Zohar, Stephanie Fischinger, Caroline Atyeo, John S. Burke, et al. (+16)
102 [GO] 2021―Feb―08 Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera Xuping Xie, Yang Liu, Jianying Liu, Xianwen Zhang, Jing Zou, Camila R. Fontes-Garfias, et al. (+8)
103 [GO] 2021―Feb―06 Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege Alexander W. Charney, Nicole W. Simons, Konstantinos Mouskas, Lauren Lepow, Esther Cheng, Jessica Le Berichel, et al. (+52)
104 [GO] 2021―Feb―04 COVID-19 survivors at 6 months Jennifer Sargent
105 [GO] 2021―Feb―04 COVID-19 vaccines: acting on the evidence
106 [GO] 2021―Feb―02 Sixteen novel lineages of SARS-CoV-2 in South Africa Houriiyah Tegally, Eduan Wilkinson, Richard J. Lessells, Jennifer Giandhari, Sureshnee Pillay, Nokukhanya Msomi, et al. (+25)
107 [GO] 2021―Feb―02 Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa Benjamin L. Rice, Akshaya Annapragada, Rachel E. Baker, Marjolein Bruijning, Winfred Dotse-Gborgbortsi, Keitly Mensah, et al. (+11)
108 [GO] 2021―Feb―02 Author Correction: Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries Vasilis Kontis, James E. Bennett, Theo Rashid, Robbie M. Parks, Jonathan Pearson-Stuttard, Michel Guillot, et al. (+8)
109 [GO] 2021―Jan―28 Neurological effects of COVID-19 in children Hannah Stower
110 [GO] 2021―Jan―25 Ethical considerations of COVID-19-related adjustments to clinical research Nina S. Hsu, Saskia Hendriks, Khara M. Ramos, Christine Grady
111 [GO] 2021―Jan―19 Looking beyond COVID-19 vaccine phase 3 trials Jerome H. Kim, Florian Marks, John D. Clemens
112 [GO] 2021―Jan―13 Immune determinants of COVID-19 disease presentation and severity Petter Brodin
113 [GO] 2021―Jan―13 What do journalists say about covering science during the COVID-19 pandemic? Anita Makri
114 [GO] 2021―Jan―13 On the origins of SARS-CoV-2 Angela L. Rasmussen
115 [GO] 2021―Jan―11 Automated screening of COVID-19 preprints: can we help authors to improve transparency and reproducibility? Tracey Weissgerber, Nico Riedel, Halil Kilicoglu, Cyril Labbé, Peter Eckmann, Gerben ter Riet, et al. (+11)
116 [GO] 2021―Jan―11 Author Correction: A global survey of potential acceptance of a COVID-19 vaccine Jeffrey V. Lazarus, Scott C. Ratzan, Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, et al. (+2)
117 [GO] 2020―Dec―18 Difficult trade-offs in response to COVID-19: the case for open and inclusive decision making Ole F. Norheim, Joelle M. Abi-Rached, Liam Kofi Bright, Kristine Bærøe, Octávio L. M. Ferraz, Siri Gloppen, Alex Voorhoeve
118 [GO] 2020―Dec―17 Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses Jordan R. Barrett, Sandra Belij-Rammerstorfer, Christina Dold, Katie J. Ewer, Pedro M. Folegatti, Ciaran Gilbride, et al. (+48)
119 [GO] 2020―Dec―17 T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial Katie J. Ewer, Jordan R. Barrett, Sandra Belij-Rammerstorfer, Hannah Sharpe, Rebecca Makinson, Richard Morter, et al. (+40)
120 [GO] 2020―Dec―11 Individual and community-level risk for COVID-19 mortality in the United States Jin Jin, Neha Agarwala, Prosenjit Kundu, Benjamin Harvey, Yuqi Zhang, Eliza Wallace, Nilanjan Chatterjee
121 [GO] 2020―Dec―07 COVID-19 clusters Thiago Carvalho
122 [GO] 2020―Dec―07 Interferon linked to COVID-19 severity Thiago Carvalho
123 [GO] 2020―Dec―07 COVID-19-induced Kawasaki disease Thiago Carvalho
124 [GO] 2020―Dec―07 COVID-19: what health experts could and could not predict Devi Sridhar
125 [GO] 2020―Dec―07 Extrapulmonary SARS-CoV-2 manifestations Thiago Carvalho
126 [GO] 2020―Nov―30 Toward superhuman SARS-CoV-2 immunity? Dennis R. Burton, Eric J. Topol
127 [GO] 2020―Nov―30 Effective control of SARS-CoV-2 transmission in Wanzhou, China Qiuling Shi, Yaoyue Hu, Bin Peng, Xiao-Jun Tang, Wei Wang, Kun Su, et al. (+9)
128 [GO] 2020―Nov―27 Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Abhishek Das, Matthew Fish, Leticia Monin, et al. (+44)
129 [GO] 2020―Nov―27 Author Correction: Modeling COVID-19 scenarios for the United States
130 [GO] 2020―Nov―27 Publisher Correction: Responding to the hidden pandemic for healthcare workers: stress John H. Krystal
131 [GO] 2020―Nov―23 Will patient-centric sampling become the norm for clinical trials after COVID-19? Christopher A. James, Matthew D. Barfield, Katie F. Maass, Shefali R. Patel, Melanie D. Anderson
132 [GO] 2020―Nov―23 Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates Molly E. Gallagher, Andrew J. Sieben, Kristin N. Nelson, Alicia N. M. Kraay, Walter A. Orenstein, Ben Lopman, et al. (+2)
133 [GO] 2020―Nov―12 Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells Isabel Schulien, Janine Kemming, Valerie Oberhardt, Katharina Wild, Lea M. Seidel, Saskia Killmer, et al. (+25)
134 [GO] 2020―Oct―30 Diversifying the biomedical workforce during the COVID-19 pandemic Long H. Nguyen, Aswita Tan-McGrory, Alice Y. Oh, Esteban A. Barreto, Stephen J. Bartels, Katrina A. Armstrong, et al. (+2)
135 [GO] 2020―Oct―29 Wearable sensor data and self-reported symptoms for COVID-19 detection Giorgio Quer, Jennifer M. Radin, Matteo Gadaleta, Katie Baca-Motes, Lauren Ariniello, Edward Ramos, et al. (+3)
136 [GO] 2020―Oct―23 Modeling COVID-19 scenarios for the United States
137 [GO] 2020―Oct―22 Understanding protection from SARS-CoV-2 by studying reinfection Julie Overbaugh
138 [GO] 2020―Oct―20 A global survey of potential acceptance of a COVID-19 vaccine Jeffrey V. Lazarus, Scott C. Ratzan, Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, et al. (+2)
139 [GO] 2020―Oct―20 Author Correction: Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands Bas B. Oude Munnink, David F. Nieuwenhuijse, Mart Stein, Áine O’Toole, Manon Haverkate, Madelief Mollers, et al. (+19)
140 [GO] 2020―Oct―16 Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in France Nicolas Hoertel, Martin Blachier, Carlos Blanco, Mark Olfson, Marc Massetti, Marina Sánchez Rico, et al. (+2)
141 [GO] 2020―Oct―14 Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries Vasilis Kontis, James E. Bennett, Theo Rashid, Robbie M. Parks, Jonathan Pearson-Stuttard, Michel Guillot, et al. (+8)
142 [GO] 2020―Oct―09 COVID-19 puts the Sustainable Development Goals center stage Ole Petter Ottersen, Eivind Engebretsen
143 [GO] 2020―Oct―05 Crowding and the shape of COVID-19 epidemics Benjamin Rader, Samuel V. Scarpino, Anjalika Nande, Alison L. Hill, Ben Adlam, Robert C. Reiner, et al. (+10)
144 [GO] 2020―Sep―22 COVID-19 clinical trials: learning from exceptions in the research chaos Kari A. O. Tikkinen, Reza Malekzadeh, Martin Schlegel, Jarno Rutanen, Paul Glasziou
145 [GO] 2020―Sep―17 Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong Dillon C. Adam, Peng Wu, Jessica Y. Wong, Eric H. Y. Lau, Tim K. Tsang, Simon Cauchemez, et al. (+2)
146 [GO] 2020―Sep―15 Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study Sean T. H. Liu, Hung-Mo Lin, Ian Baine, Ania Wajnberg, Jeffrey P. Gumprecht, Farah Rahman, et al. (+24)
147 [GO] 2020―Sep―14 Seasonal coronavirus protective immunity is short-lasting Arthur W. D. Edridge, Joanna Kaczorowska, Alexis C. R. Hoste, Margreet Bakker, Michelle Klein, Katherine Loens, et al. (+10)
148 [GO] 2020―Sep―10 Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Abhishek Das, Matthew Fish, Leticia Monin, et al. (+44)
149 [GO] 2020―Sep―10 Developing COVID-19 vaccines Hannah Stower
150 [GO] 2020―Sep―04 Controlling the COVID-19 pandemic in Brazil: a challenge of continental proportions Mayra Monteiro de Oliveira, Trevon L. Fuller, Patricia Brasil, Claudia R. Gabaglia, Karin Nielsen-Saines
151 [GO] 2020―Sep―03 Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters Lisa H. Tostanoski, Frank Wegmann, Amanda J. Martinot, Carolin Loos, Katherine McMahan, Noe B. Mercado, et al. (+38)
152 [GO] 2020―Aug―24 COVID-19 puts health research to the test in Africa Paul Adepoju
153 [GO] 2020―Aug―24 An inflammatory cytokine signature predicts COVID-19 severity and survival Diane Marie Del Valle, Seunghee Kim-Schulze, Hsin-Hui Huang, Noam D. Beckmann, Sharon Nirenberg, Bo Wang, et al. (+26)
154 [GO] 2020―Aug―24 Vaccines targeting SARS-CoV-2 tested in humans Kathryn M. Edwards
155 [GO] 2020―Aug―21 Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege Alexander W. Charney, Nicole W. Simons, Konstantinos Mouskas, Lauren Lepow, Esther Cheng, Jessica Le Berichel, et al. (+50)
156 [GO] 2020―Aug―18 Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China Xin Xu, Jian Sun, Sheng Nie, Huiyuan Li, Yaozhong Kong, Min Liang, et al. (+16)
157 [GO] 2020―Aug―18 Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection Michael J. Carter, Matthew Fish, Aislinn Jennings, Katie J. Doores, Paul Wellman, Jeffrey Seow, et al. (+8)
158 [GO] 2020―Aug―17 A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Abhishek Das, Matthew Fish, Leticia Monin, et al. (+44)
159 [GO] 2020―Aug―17 Effects of disruption from COVID-19 on antimalarial strategies Rashid Ansumana, Osman Sankoh, Alimuddin Zumla
160 [GO] 2020―Aug―17 Is presymptomatic spread a major contributor to COVID-19 transmission? Mark K. Slifka, Lina Gao
161 [GO] 2020―Aug―17 Reply to: Is presymptomatic spread a major contributor to COVID-19 transmission? Eric H. Y. Lau, Gabriel M. Leung
162 [GO] 2020―Aug―07 Brazil’s policies condemn Amazonia to a second wave of COVID-19 Lucas Ferrante, Wilhelm Alexander Steinmetz, Alexandre Celestino Leite Almeida, Jeremias Leão, Ruth Camargo Vassão, Unaí Tupinambás, et al. (+2)
163 [GO] 2020―Aug―07 Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19 Xi He, Eric H. Y. Lau, Peng Wu, Xilong Deng, Jian Wang, Xinxin Hao, et al. (+17)
164 [GO] 2020―Aug―07 Regulatory, safety, and privacy concerns of home monitoring technologies during COVID-19 Sara Gerke, Carmel Shachar, Peter R. Chai, I. Glenn Cohen
165 [GO] 2020―Aug―07 Digital technologies in the public-health response to COVID-19 Jobie Budd, Benjamin S. Miller, Erin M. Manning, Vasileios Lampos, Mengdie Zhuang, Michael Edelstein, et al. (+11)
166 [GO] 2020―Aug―07 Using a real-world network to model localized COVID-19 control strategies Josh A. Firth, Joel Hellewell, Petra Klepac, Stephen Kissler, Adam J. Kucharski, Lewis G. Spurgin
167 [GO] 2020―Aug―07 The potential public health consequences of COVID-19 on malaria in Africa Ellie Sherrard-Smith, Alexandra B. Hogan, Arran Hamlet, Oliver J. Watson, Charlie Whittaker, Peter Winskill, et al. (+23)
168 [GO] 2020―Aug―07 Seeds of hope in COVID-19 vaccine preliminary data Hannah Stower
169 [GO] 2020―Aug―03 Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection Vijendra Ramlall, Phyllis M. Thangaraj, Cem Meydan, Jonathan Foox, Daniel Butler, Jacob Kim, et al. (+6)
170 [GO] 2020―Jul―27 Assessing the extent of SARS-CoV-2 circulation through serological studies Marion Koopmans, Bart Haagmans
171 [GO] 2020―Jul―27 Sampling the host response to SARS-CoV-2 in hospitals under siege Alexander W. Charney, Nicole W. Simons, Konstantinos Mouskas, Lauren Lepow, Esther Cheng, Jessica Le Berichel, et al. (+50)
172 [GO] 2020―Jul―16 Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands Bas B. Oude Munnink, David F. Nieuwenhuijse, Mart Stein, Áine O’Toole, Manon Haverkate, Madelief Mollers, et al. (+19)
173 [GO] 2020―Jul―15 How computational immunology changed the face of COVID-19 vaccine development Carrie Arnold
174 [GO] 2020―Jul―14 A stochastic agent-based model of the SARS-CoV-2 epidemic in France Nicolas Hoertel, Martin Blachier, Carlos Blanco, Mark Olfson, Marc Massetti, Marina Sánchez Rico, et al. (+2)
175 [GO] 2020―Jul―13 Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 Jennifer A. Juno, Hyon-Xhi Tan, Wen Shi Lee, Arnold Reynaldi, Hannah G. Kelly, Kathleen Wragg, et al. (+14)
176 [GO] 2020―Jul―10 Extrapulmonary manifestations of COVID-19 Aakriti Gupta, Mahesh V. Madhavan, Kartik Sehgal, Nandini Nair, Shiwani Mahajan, Tejasav S. Sehrawat, et al. (+23)
177 [GO] 2020―Jul―10 Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein Seth J. Zost, Pavlo Gilchuk, Rita E. Chen, James Brett Case, Joseph X. Reidy, Andrew Trivette, et al. (+25)
178 [GO] 2020―Jul―10 The ethics of deferred consent in times of pandemics Rieke van der Graaf, Marie-Astrid Hoogerwerf, Martine C. de Vries
179 [GO] 2020―Jul―09 Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling Rebecca J. Rockett, Alicia Arnott, Connie Lam, Rosemarie Sadsad, Verlaine Timms, Karen-Ann Gray, et al. (+18)
180 [GO] 2020―Jul―08 Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil Mariângela F. Silveira, Aluísio J. D. Barros, Bernardo L. Horta, Lúcia C. Pellanda, Gabriel D. Victora, Odir A. Dellagostin, et al. (+15)
181 [GO] 2020―Jul―02 COVID-19 Research in Brief: 30 May to 5 June, 2020 Thiago Carvalho
182 [GO] 2020―Jun―26 COVID-19 Research in Brief: December, 2019 to June, 2020 Thiago Carvalho
183 [GO] 2020―Jun―26 Publisher Correction: Building an international consortium for tracking coronavirus health status Eran Segal, Feng Zhang, Xihong Lin, Gary King, Ophir Shalem, Smadar Shilo, et al. (+47)
184 [GO] 2020―Jun―24 Determinants of COVID-19 disease severity in patients with cancer Elizabeth V. Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocio Perez-Johnston, Marilia Bernardes, et al. (+22)
185 [GO] 2020―Jun―19 COVID-19 Research in Brief: 13 June to 19 June, 2020 Thiago Carvalho
186 [GO] 2020―Jun―18 Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Quan-Xin Long, Xiao-Jun Tang, Qiu-Lin Shi, Qin Li, Hai-Jun Deng, Jun Yuan, et al. (+13)
187 [GO] 2020―Jun―16 Age-dependent effects in the transmission and control of COVID-19 epidemics Nicholas G. Davies, Petra Klepac, Yang Liu, Kiesha Prem, Mark Jit, Rosalind M. Eggo
188 [GO] 2020―Jun―16 Disease and healthcare burden of COVID-19 in the United States Ian F. Miller, Alexander D. Becker, Bryan T. Grenfell, C. Jessica E. Metcalf
189 [GO] 2020―Jun―16 COVID-19 Research in Brief: 6 June to 12 June, 2020 Thiago Carvalho
190 [GO] 2020―Jun―15 Biobanks could identify medically actionable findings relevant for COVID-19 clinical care Andrew B. Stergachis, Scott T. Weiss, Robert C. Green
191 [GO] 2020―Jun―11 Keeping governments accountable: the COVID-19 Assessment Scorecard (COVID-SCORE) Jeffrey V. Lazarus, Agnes Binagwaho, Ayman A. E. El-Mohandes, Jonathan E. Fielding, Heidi J. Larson, Antoni Plasència, et al. (+2)
192 [GO] 2020―Jun―11 COVID-19 in Africa: the spread and response Marguerite Massinga Loembé, Akhona Tshangela, Stephanie J. Salyer, Jay K. Varma, Ahmed E. Ogwell Ouma, John N. Nkengasong
193 [GO] 2020―Jun―11 Socio-demographic and epidemiological consideration of Africa’s COVID-19 response: what is the possible pandemic course? Bamba Gaye, Stéphanie Khoury, Crystal W. Cene, Samuel Kingue, Roland N’Guetta, Camille Lassale, et al. (+5)
194 [GO] 2020―Jun―11 Kawasaki disease in a COVID-19-struck region Hannah Stower
195 [GO] 2020―Jun―08 A single-cell atlas of the peripheral immune response in patients with severe COVID-19 Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao, Jonasel Roque, Giovanny J. Martínez-Colón, Julia L. McKechnie, et al. (+9)
196 [GO] 2020―Jun―08 Preserve junior faculty in biomedical sciences during and after the pandemic Prachee Avasthi, Ushma S. Neill, Keshia M. Pollack Porter, Ashani T. Weeraratna
197 [GO] 2020―Jun―05 Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China Xin Xu, Jian Sun, Sheng Nie, Huiyuan Li, Yaozhong Kong, Min Liang, et al. (+16)
198 [GO] 2020―Jun―03 Author Correction: Caring for patients with cancer in the COVID-19 era Joris van de Haar, Louisa R. Hoes, Charlotte E. Coles, Kenneth Seamon, Stefan Fröhling, Dirk Jäger, et al. (+15)
199 [GO] 2020―Jun―02 Building an international consortium for tracking coronavirus health status Eran Segal, Feng Zhang, Xihong Lin, Gary King, Ophir Shalem, Smadar Shilo, et al. (+47)
200 [GO] 2020―May―29 COVID-19 Research in Brief: 23 May to 29 May, 2020 Thiago Carvalho
201 [GO] 2020―May―26 Use of apps in the COVID-19 response and the loss of privacy protection Tanusree Sharma, Masooda Bashir
202 [GO] 2020―May―26 Mass-surveillance technologies to fight coronavirus spread: the case of Israel Moran Amit, Heli Kimhi, Tarif Bader, Jacob Chen, Elon Glassberg, Avi Benov
203 [GO] 2020―May―22 COVID-19 Research in Brief: 16 May to 22 May, 2020 Thiago Carvalho
204 [GO] 2020―May―22 Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence Vineet D. Menachery, Boyd L. Yount, Kari Debbink, Sudhakar Agnihothram, Lisa E. Gralinski, Jessica A. Plante, et al. (+9)
205 [GO] 2020―May―21 Low- and middle-income countries face up to COVID-19 Miriam Shuchman
206 [GO] 2020―May―21 Addendum: Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China Joseph T. Wu, Kathy Leung, Mary Bushman, Nishant Kishore, Rene Niehus, Pablo M. de Salazar, et al. (+3)
207 [GO] 2020―May―19 Artificial intelligence-enabled rapid diagnosis of patients with COVID-19 Xueyan Mei, Hao-Chih Lee, Kai-yue Diao, Mingqian Huang, Bin Lin, Chenyu Liu, et al. (+22)
208 [GO] 2020―May―15 15 drugs being tested to treat COVID-19 and how they would work Leah Shaffer
209 [GO] 2020―May―15 COVID-19 Research in Brief: 9 May to 15 May, 2020 Thiago Carvalho
210 [GO] 2020―May―13 Infection of bat and human intestinal organoids by SARS-CoV-2 Jie Zhou, Cun Li, Xiaojuan Liu, Man Chun Chiu, Xiaoyu Zhao, Dong Wang, et al. (+14)
211 [GO] 2020―May―12 Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 Mingfeng Liao, Yang Liu, Jing Yuan, Yanling Wen, Gang Xu, Juanjuan Zhao, et al. (+8)
212 [GO] 2020―May―12 The fight to end tuberculosis must not be forgotten in the COVID-19 outbreak Tsegahun Manyazewal, Yimtubezinash Woldeamanuel, Henry M. Blumberg, Abebaw Fekadu, Vincent C. Marconi
213 [GO] 2020―May―12 ‘Test, re-test, re-test’: using inaccurate tests to greatly increase the accuracy of COVID-19 testing Kamalini Ramdas, Ara Darzi, Sanjay Jain
214 [GO] 2020―May―12 A serological assay to detect SARS-CoV-2 seroconversion in humans Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, Thi H. O. Nguyen, Veronika Chromikova, Meagan McMahon, et al. (+24)
215 [GO] 2020―May―11 Real-time tracking of self-reported symptoms to predict potential COVID-19 Cristina Menni, Ana M. Valdes, Maxim B. Freidin, Carole H. Sudre, Long H. Nguyen, David A. Drew, et al. (+14)
216 [GO] 2020―May―11 Supporting the UK National Health Service during the COVID-19 crisis from an academic perspective Matthias Trost
217 [GO] 2020―May―11 COVID-19 in Padua, Italy: not just an economic and health issue Francesco Paolo Russo
218 [GO] 2020―May―11 Fast and frugal innovations in response to the COVID-19 pandemic Matthew Harris, Yasser Bhatti, Jim Buckley, Dhananjaya Sharma
219 [GO] 2020―May―08 COVID-19 Research in Brief: 2 May to 8 May, 2020 Thiago Carvalho
220 [GO] 2020―May―07 Protect against market exclusivity in the fight against COVID-19 Ellen ’t Hoen
221 [GO] 2020―May―07 Modeling shield immunity to reduce COVID-19 epidemic spread Joshua S. Weitz, Stephen J. Beckett, Ashley R. Coenen, David Demory, Marian Dominguez-Mirazo, Jonathan Dushoff, et al. (+7)
222 [GO] 2020―May―07 Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry Paul Hofman, Pascal Puchois, Patrick Brest, Hicham Lahlou, Daniel Simeon-Dubach
223 [GO] 2020―May―01 An overdose surge will compound the COVID-19 pandemic if urgent action is not taken Sarah E. Wakeman, Traci C. Green, Josiah Rich
224 [GO] 2020―May―01 COVID-19 Research in Brief: 24 April to 1 May, 2020 Thiago Carvalho
225 [GO] 2020―Apr―29 Antibody responses to SARS-CoV-2 in patients with COVID-19 Quan-Xin Long, Bai-Zhong Liu, Hai-Jun Deng, Gui-Cheng Wu, Kun Deng, Yao-Kai Chen, et al. (+45)
226 [GO] 2020―Apr―29 Responding to the hidden pandemic for healthcare workers: stress John H. Krystal, Robert L. McNeil
227 [GO] 2020―Apr―27 Antibody testing will enhance the power and accuracy of COVID-19-prevention trials Marc Lipsitch, Rebecca Kahn, Michael J. Mina
228 [GO] 2020―Apr―24 COVID-19 Research in Brief: 18 April to 24 April, 2020 Thiago Carvalho
229 [GO] 2020―Apr―24 The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin Ehud Chorin, Matthew Dai, Eric Shulman, Lalit Wadhwani, Roi Bar-Cohen, Chirag Barbhaiya, et al. (+7)
230 [GO] 2020―Apr―23 Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States
231 [GO] 2020―Apr―23 SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes Waradon Sungnak, Ni Huang, Christophe Bécavin, Marijn Berg, Rachel Queen, Monika Litvinukova, et al. (+7)
232 [GO] 2020―Apr―22 Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy Giulia Giordano, Franco Blanchini, Raffaele Bruno, Patrizio Colaneri, Alessandro Di Filippo, Angela Di Matteo, Marta Colaneri
233 [GO] 2020―Apr―17 COVID-19 Research in Brief: 11 April to 17 April, 2020 Thiago Carvalho
234 [GO] 2020―Apr―17 Biomedical research: lessons from the last decade’s crisis and austerity-stricken small countries for the current COVID-19-related crisis George P. Chrousos, Alexios-Fotios A. Mentis, Efthimios Dardiotis
235 [GO] 2020―Apr―16 Caring for patients with cancer in the COVID-19 era Joris van de Haar, Louisa R. Hoes, Charlotte E. Coles, Kenneth Seamon, Stefan Fröhling, Dirk Jäger, et al. (+15)
236 [GO] 2020―Apr―16 How is biomedical research funding faring during the COVID-19 lockdown? Paul Webster
237 [GO] 2020―Apr―15 Temporal dynamics in viral shedding and transmissibility of COVID-19 Xi He, Eric H. Y. Lau, Peng Wu, Xilong Deng, Jian Wang, Xinxin Hao, et al. (+17)
238 [GO] 2020―Apr―14 COVID-19 Research in Brief: 4 April to 10 April, 2020 Thiago Carvalho
239 [GO] 2020―Apr―14 Coping with COVID-19: scaling up virtual care to standard practice Esther Z. Barsom, Tim M. Feenstra, Willem A. Bemelman, Jaap H. Bonjer, Marlies P. Schijven
240 [GO] 2020―Apr―09 Lopinavir-ritonavir in severe COVID-19 Hannah Stower
241 [GO] 2020―Apr―09 Clinical and epidemiological characteristics of children with COVID-19 Hannah Stower
242 [GO] 2020―Apr―09 A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys Hagai Rossman, Ayya Keshet, Smadar Shilo, Amir Gavrieli, Tal Bauman, Ori Cohen, et al. (+5)
243 [GO] 2020―Apr―09 If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future Martin McKee, David Stuckler
244 [GO] 2020―Apr―09 Functionally assessing coronavirus entry Hannah Stower
245 [GO] 2020―Apr―09 Spread of SARS-CoV-2 Hannah Stower
246 [GO] 2020―Apr―09 Virological assessment of SARS-CoV-2 Hannah Stower
247 [GO] 2020―Apr―08 Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus Deepak Jakhar, Ishmeet Kaur
248 [GO] 2020―Apr―08 COVID-19 in humanitarian settings and lessons learned from past epidemics Ling San Lau, Goleen Samari, Rachel T. Moresky, Sara E. Casey, S. Patrick Kachur, Leslie F. Roberts, Monette Zard
249 [GO] 2020―Apr―03 COVID-19 Research in Brief: 28 March to 3 April, 2020 Thiago Carvalho
250 [GO] 2020―Apr―02 Safeguard research in the time of COVID-19
251 [GO] 2020―Mar―27 Digital technology and COVID-19 Daniel Shu Wei Ting, Lawrence Carin, Victor Dzau, Tien Y. Wong
252 [GO] 2020―Mar―27 On the responsible use of digital data to tackle the COVID-19 pandemic Marcello Ienca, Effy Vayena
253 [GO] 2020―Mar―27 COVID-19 Research in Brief: 20 March to 27 March, 2020 Thiago Carvalho
254 [GO] 2020―Mar―26 COVID-19: Biomedical research in a world under social-distancing measures Carrie Arnold
255 [GO] 2020―Mar―26 Combating COVID-19: health equity matters Zhicheng Wang, Kun Tang
256 [GO] 2020―Mar―19 Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China Joseph T. Wu, Kathy Leung, Mary Bushman, Nishant Kishore, Rene Niehus, Pablo M. de Salazar, et al. (+3)
257 [GO] 2020―Mar―17 The proximal origin of SARS-CoV-2 Kristian G. Andersen, Andrew Rambaut, W. Ian Lipkin, Edward C. Holmes, Robert F. Garry
258 [GO] 2020―Mar―16 Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 Irani Thevarajan, Thi H. O. Nguyen, Marios Koutsakos, Julian Druce, Leon Caly, Carolien E. van de Sandt, et al. (+7)
259 [GO] 2020―Mar―13 Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding Yi Xu, Xufang Li, Bing Zhu, Huiying Liang, Chunxiao Fang, Yu Gong, et al. (+10)
260 [GO] 2020―Mar―11 Nigeria responds to COVID-19; first case detected in sub-Saharan Africa Paul Adepoju
261 [GO] 2020―Mar―11 Lack of maternal-fetal SARS-CoV-2 transmission Hannah Stower
262 [GO] 2020―Mar―09 In the fight against the new coronavirus outbreak, we must also struggle with human bias Joana Gonçalves-Sá
263 [GO] 2020―Mar―05 Author Correction: China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response John Nkengasong
264 [GO] 2020―Feb―27 Emergence of a novel human coronavirus threatening human health Leo L. M. Poon, Malik Peiris
265 [GO] 2020―Feb―19 Four ways researchers are responding to the COVID-19 outbreak Amanda B. Keener
266 [GO] 2020―Feb―03 Communication, collaboration and cooperation can stop the 2019 coronavirus
267 [GO] 2020―Jan―27 China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response John Nkengasong


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.166 sec